Considering that “the joke in the field is: The male pill’s been five to 10 years away for the last 30 years,” I’m not holding by breath. But apparently Vasalgel, a long-term reversible form of birth control that blocks sperm after a single injection, is entering human trials and could hit the market by 2017.

At The Daily Beast, Samantha Allen touches on some the barriers to birth control innovations like these. Long-term treatments like Vasalgel often don’t get much funding in a pharmaceutical industry that maximizes profits by selling us uterus-having folks hormonal birth control that must be taken regularly. “Why sell a flat-screen television to a man, after all, when you can rent one to ...